ADVERTISEMENT
Press release content from PR Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

Life-changing Medicines Arcalyst and Gavreto Now Available at AllianceRx Walgreens Prime

September 28, 2021 GMT
(PRNewsfoto/AllianceRx Walgreens Prime)
(PRNewsfoto/AllianceRx Walgreens Prime)
(PRNewsfoto/AllianceRx Walgreens Prime)

ORLANDO, Fla., Sept. 28, 2021 /PRNewswire/ -- Medicines prescribed for the treatment of specific kinds of cancer as well as an autoinflammatory cardiovascular disease are now available through AllianceRx Walgreens Prime.

Arcalyst ® (rilonacept) is the first and only FDA-approved product for the treatment of recurrent pericarditis and reduction in risk of recurrence. Pericarditis is a painful and debilitating autoinflammatory cardiovascular disease associated with swelling of the saclike membrane surrounding the heart. Arcalyst is also approved by the FDA for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), a group of rare hereditary autoinflammatory disorders, including Familial Cold Autoinflammatory Syndrome and Muckle-Wells Syndrome, and for the maintenance of remission of Deficiency of Interleukin-1 Receptor Antagonist (DIRA), an autoinflammatory disease affecting fewer than 50 people worldwide. Kiniksa Pharmaceuticals manufactures Arcalyst, which is also a registered trademark of Regeneron Pharmaceuticals, Inc.

ADVERTISEMENT

Gavreto ® (pralsetinib) is a once-daily oral prescription medicine used to treat certain cancers caused by abnormal RET-positive (rearranged during transfection) genes in non-small-cell lung cancer that has spread (metastatic) or advanced thyroid cancer that may have spread. Blueprint Medicines manufactures Gavreto.

“Patients living with these rare autoinflammatory disorders and cancers deserve access to the best treatment options available to help them manage these conditions,” says Tracey James, senior vice president of Pharmacy Services. “We are delighted these manufacturers chose AllianceRx Walgreens Prime to dispense these medications. Our specialty pharmacists engage and counsel patients about prescribed therapy and help improve adherence and persistence. Manufacturers partner with us because of our continual commitment to providing patients with individualized support and clinical expertise required to improve patient outcomes.”

ADVERTISEMENT

For full prescribing information and warnings for any of these medicines, visit the manufacturer websites or dailymed.nlm.nih.gov.

About AllianceRx Walgreens Prime
AllianceRx Walgreens Prime ( alliancerxwp.com ) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient’s treatment journey with the medications they need every day. Formed in 2017 through a collaboration between Walgreens, one of the nation’s largest chain drug stores, and Prime Therapeutics, a leading pharmacy benefit manager, the company offers tools and resources for patients, providers, and health plans to deliver the optimal health outcomes. The company is headquartered in Orlando, Fla. and its pharmacies are accredited by several national pharmacy accreditation services.

Media Contact
Adrienne Foley, APR
External communications manager
adrienne.foley1@alliancerxwp.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/life-changing-medicines-arcalyst-and-gavreto-now-available-at-alliancerx-walgreens-prime-301386571.html

SOURCE AllianceRx Walgreens Prime